Sutter Bay Hospitals

🇺🇸United States
Ownership
Private
Employees
-
Market Cap
-
Website

The Effects of Successful OSA Treatment on Memory and AD Biomarkers in Older Adults Study

First Posted Date
2023-08-14
Last Posted Date
2024-08-09
Lead Sponsor
California Pacific Medical Center Research Institute
Target Recruit Count
200
Registration Number
NCT05988385
Locations
🇺🇸

University of Pittsburgh, Pittsburgh, Pennsylvania, United States

🇺🇸

University of Arizona, Tucson, Arizona, United States

🇺🇸

New York University, New York, New York, United States

and more 1 locations

A Study of Concurrent Stereotactic Body Radiotherapy With Opdualag in Metastatic Uveal Melanoma

First Posted Date
2021-10-14
Last Posted Date
2022-12-06
Lead Sponsor
California Pacific Medical Center Research Institute
Target Recruit Count
40
Registration Number
NCT05077280
Locations
🇺🇸

California Pacific Medical Center Research Institute, San Francisco, California, United States

Phase II Study of Olaparib and Pembrolizumab in Advanced Melanoma With Homologous Recombination (HR) Mutation

Phase 2
Recruiting
Conditions
Interventions
First Posted Date
2020-11-18
Last Posted Date
2022-12-06
Lead Sponsor
California Pacific Medical Center Research Institute
Target Recruit Count
41
Registration Number
NCT04633902
Locations
🇺🇸

The University of Texas MD Anderson Cancer Center, Houston, Texas, United States

🇺🇸

California Pacific Medical Center Research Institute, San Francisco, California, United States

CBT-I or Zolpidem/Trazodone for Insomnia

First Posted Date
2020-07-13
Last Posted Date
2024-07-19
Lead Sponsor
California Pacific Medical Center Research Institute
Target Recruit Count
155
Registration Number
NCT04468776
Locations
🇺🇸

University of Missouri, Columbia, Missouri, United States

🇺🇸

Penn State Hershey Medical Center, Hershey, Pennsylvania, United States

🇺🇸

University of Virginia, Charlottesville, Virginia, United States

and more 4 locations

Efficacy and Safety Study of Niraparib in Melanoma With Genetic Homologous Recombination (HR) Mutation

Phase 2
Conditions
Interventions
First Posted Date
2019-04-24
Last Posted Date
2021-10-22
Lead Sponsor
California Pacific Medical Center Research Institute
Target Recruit Count
41
Registration Number
NCT03925350
Locations
🇺🇸

California Pacific Medical Center Research Institute, San Francisco, California, United States

Trial of Parkinson's And Zoledronic Acid

First Posted Date
2019-04-23
Last Posted Date
2024-08-21
Lead Sponsor
California Pacific Medical Center Research Institute
Target Recruit Count
3500
Registration Number
NCT03924414
Locations
🇺🇸

Cedars-Sinai Medical Center, Los Angeles, California, United States

🇺🇸

St. Mary's Medical Center, Grand Junction, Colorado, United States

🇺🇸

Hartford Healthcare, Hartford, Connecticut, United States

and more 67 locations

The Impact of Workplace Food and Beverage Choices on Health and Wellness

Not Applicable
Conditions
Interventions
First Posted Date
2018-02-13
Last Posted Date
2022-08-12
Lead Sponsor
California Pacific Medical Center Research Institute
Target Recruit Count
648
Registration Number
NCT03431051
Locations
🇺🇸

California Pacific Medical Center, San Francisco, California, United States

The Hepatitis B e-Antigen Negative Disease - Directly Offered Study of Treatment Withdrawal in Patients With e-Antigen Negative Chronic HBV Infection (BeNEG-DO).

Not Applicable
Active, not recruiting
Conditions
Interventions
First Posted Date
2016-07-27
Last Posted Date
2023-07-07
Lead Sponsor
California Pacific Medical Center Research Institute
Target Recruit Count
121
Registration Number
NCT02845401
Locations
🇺🇸

University of California, San Francisco, San Francisco, California, United States

🇺🇸

California Pacific Medical Center, San Francisco, California, United States

Mindfulness and Migraine Research Study

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2016-07-06
Last Posted Date
2020-06-18
Lead Sponsor
California Pacific Medical Center Research Institute
Target Recruit Count
66
Registration Number
NCT02824250
Locations
🇺🇸

Palo Alto Medical Foundation Research Institute, Palo Alto, California, United States

A Phase II Trial of Sunitinib and Nivolumab for KIT-mutated Advanced Melanoma

Phase 2
Withdrawn
Conditions
Interventions
First Posted Date
2015-03-27
Last Posted Date
2017-02-01
Lead Sponsor
California Pacific Medical Center Research Institute
Registration Number
NCT02400385
Locations
🇺🇸

California Pacific Medical Center Research Institute, San Francisco, California, United States

© Copyright 2024. All Rights Reserved by MedPath